Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • cmccabe
    Senior Member
    • Jul 2012
    • 355

    GATK command options

    I just want to be sure that I am interpreting the below correct:

    In this GATK command the -L 20 gives the chromosome 20 only and if all chromosomes were used then the -L can be removed.

    The -known is only used if your organism has a file (maybe hg19 does, but I have to search). Is it a text file?

    Code:
    java -jar GenomeAnalysisTK.jar \ 
        -T RealignerTargetCreator \ 
        -R reference.fa \ 
        -I dedup_reads.bam \ 
        [B][B]-L 20 \ [/B][/B]       (chromomosome 20 only)
        [I]-known gold_indels.vcf \ [/I]   (optional) 
        -o realignment_targets.list
    
    Expected Result
    
    This creates a file called realignment_targets.list containing the list of intervals that the program identified as needing realignment within our target, chromosome 20.
    
    The list of known indel sites (gold_indels.vcf) are used as targets for realignment. Only use it if there is such a list for your organism.
    In the below GATK command:

    Code:
    java -jar GenomeAnalysisTK.jar \ 
        -T BaseRecalibrator \ 
        -R reference.fa \ 
        -I realigned_reads.bam \ 
        -L 20 \ 
        -knownSites dbsnp.vcf \ 
        -knownSites gold_indels.vcf \ 
        -o recal_data.table
    t he -L20 and -known do the same as in the previous command. Thank you .
  • HESmith
    Senior Member
    • Oct 2009
    • 512

    #2
    "gold_indels.vcf" is a VCF; see here for the latest specification.

    Comment

    • WhatsOEver
      Senior Member
      • Apr 2012
      • 215

      #3
      Concerning your question: No, "L" restricts the variant calling to a certain region (in your example chr20); "known" specifies a file containing known variants - these files contain variant info over the whole genome.

      The Broad institute offers a resource bundle for hg19 which also include the known variants (https://www.broadinstitute.org/gatk/download/)

      Comment

      • cmccabe
        Senior Member
        • Jul 2012
        • 355

        #4
        Thank you .

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          07-20-2026, 11:48 AM
        • SEQadmin2
          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by SEQadmin2



          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
          ...
          07-09-2026, 11:10 AM
        • SEQadmin2
          Cancer Drug Resistance: The Lingering Barrier to Rising Survival
          by SEQadmin2



          Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

          There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
          07-08-2026, 05:17 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, Yesterday, 12:17 PM
        0 responses
        11 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-23-2026, 11:41 AM
        0 responses
        11 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-20-2026, 11:10 AM
        0 responses
        23 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-13-2026, 10:26 AM
        0 responses
        37 views
        0 reactions
        Last Post SEQadmin2  
        Working...